May 28, 2020

Creating the new normal in pharmacovigilance

We've heard a lot about the 'new normal' lately.  The world we knew at the beginning of 2020 is very different from the world that we are now cautiously reopening. Here in Massachusetts, the final phase of reopening is even called "The New Normal".

Everyone I speak to has an opinion on how we should deal with this new normal.

I have trouble just dealing with it: 

Read More
April 17, 2020

COVID-19 Will Change Pharmacovigilance

On April 7th, Advera Health Analytics moderated a roundtable discussion with drug safety industry experts to discuss the challenges in pharmacovigilance caused by the COVID-19 crisis.

Read More